ATMOS, a Proof-of-Concept trial of inhaled mosliciguat in untreated PAH or CTEPH
Year: 2024
Type: conference-abstract
Authors: Ardeschir Ghofrani, Hanno Leuchte, Hikmet Al-Hiti, Michael Halank, Pavel Jansa, Tobias Lange, Horst Olschewski, Khodr Tello, Eva Becker-Pelster, Sandra Ligges, Johannes Nagelschmitz, Sylvia Nikkho, Sudhir Penugonda, Soundos Saleh, Paula Vesterinen, Markus Woischnik, David Jung, Grzegorz Kopec
Institutions: Universitätsklinikum Gießen und Marburg, Ludwig-Maximilians-Universität München, Institute of Clinical and Experimental Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Charles University, General University Hospital in Prague, Klinik Bad Reichenhall, University of Regensburg, University of Graz, Medical University of Graz, Graz University Hospital, Bayer (Germany), Roivant Sciences (United States), Bayer (Finland), Jagiellonian University, John Paul II Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404095988